Symptoms and Cardiovascular Risks of FH-I
At a Glance
FH-I can cause symptomless high blood pressure early in life, even when potassium is normal. Regular blood pressure checks and treatment help reduce long-term heart, brain, and blood-vessel risks. Sudden severe headache, neurological changes, or tearing chest or back pain need emergency care.
The hallmark feature of Familial Hyperaldosteronism Type I (FH-I) is high blood pressure that appears unusually early in life [1]. While most adults do not develop hypertension until middle age, patients with FH-I are often diagnosed in childhood, adolescence, or early adulthood—classically before the age of 20 [2][1].
However, it is crucial to understand that high blood pressure is often completely asymptomatic. Headaches, fatigue, or muscle weakness are nonspecific, and relying on them to gauge your blood pressure is unsafe. Diagnosis and treatment decisions must be based on measured blood pressure readings and clinician evaluation. In some families, the hypertension is very severe and difficult to control with standard medications, while in others, it may be mild or unrecognized [3][4].
The Role of Potassium
In many other forms of primary aldosteronism (overproduction of aldosterone), patients develop low blood potassium, known as hypokalemia [5]. However, in FH-I, potassium levels are much more variable [2].
- Hypokalemia is less common: Patients with FH-I are significantly less likely to have low potassium compared to people with sporadic forms of the disease [5].
- Normal levels are common: You can have perfectly normal potassium levels and still have FH-I [4].
- A normal test is not a “rule-out”: Doctors should not use a normal potassium result to rule out FH-I if other signs, like early-onset hypertension or family history, are present [4][5].
Long-Term Risks to the Heart and Vessels
Because the high blood pressure in FH-I is driven by hormones and often starts so early, it can put extra strain on the cardiovascular system over time. If not managed effectively, this can lead to premature target-organ injury [2].
- Heart Thickening: Left ventricular hypertrophy (the heart muscle thickening because it has to pump harder) has been reported in systematic reviews of FH-I cases [2].
- Eye Damage: Hypertensive retinopathy (damage to the blood vessels in the back of the eye) has also been observed in young patients in these severe case series [2].
- Early Stroke: There is a documented association between FH-I and strokes or transient ischemic attacks (TIAs, or “mini-strokes”) occurring before age 40, based on case reports and small cohorts [2][1].
- Aortic Complications: Extremely rare complications like aortic dissection have been reported in isolated case reports of exceptionally severe or untreated disease [2].
It is important to note that severe complications at very young ages (such as in childhood or early adolescence) are mostly drawn from small, severe case reports and do not represent guaranteed milestones for every patient. Strict blood pressure control is the primary way to reduce these risks.
Cerebrovascular Screening: A Shared Decision
Because of the reported association with intracranial aneurysms (weak spots in brain arteries), you should have an individualized discussion with a specialist about whether baseline brain imaging is appropriate for you or your child [6][7].
There is no universally accepted routine screening schedule for every person with FH-I. The decision to use CTA (which involves radiation and iodinated contrast) or MRA (which avoids radiation but may require sedation in young children or a different contrast agent) depends on family history, clinical phenotype, and shared decision-making with your doctor.
Red Flags: When to Seek Emergency Care
While many patients live healthy lives with proper treatment, it is vital to recognize symptoms that could indicate a serious vascular event, such as a stroke or a ruptured aneurysm [6][7].
Seek immediate medical attention if you or your child experience:
- The “Thunderclap” Headache: A sudden, agonizing headache that is the most severe the person has ever felt [7].
- Sudden Neurological Changes: Weakness or numbness on one side of the body, drooping of the face, or difficulty speaking or understanding words [2].
- Vision Loss: A sudden loss of vision or double vision.
- Sudden Chest or Back Pain: Sharp, tearing pain in the chest or between the shoulder blades [2][7].
Early diagnosis and consistent blood pressure management are the most effective ways to lower these risks and protect long-term health [8][6].
Common questions in this guide
What are the typical symptoms of familial hyperaldosteronism type I?
Can I have FH-I if my potassium level is normal?
What heart and blood-vessel problems can uncontrolled FH-I cause?
Should someone with FH-I have a brain scan to check for an aneurysm?
Which warning signs mean I should seek emergency care?
How should blood pressure be monitored in FH-I?
Get notified when new evidence is published on Familial hyperaldosteronism type I.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (8)
- 1
SFE/SFHTA/AFCE consensus on primary aldosteronism, part 5: Genetic diagnosis of primary aldosteronism.
Zennaro MC, Jeunemaitre X
Annales d'endocrinologie 2016; (77(3)):214-9.
PMID: 27315758 - 2
Systematic Review of Therapeutic Agents and Long-Term Outcomes of Familial Hyperaldosteronism Type 1.
Tan ST, Boyle V, Elston MS
Hypertension (Dallas, Tex. : 1979) 2023; (80(7)):1517-1525 doi:10.1161/HYPERTENSIONAHA.123.21054.
PMID: 37170822 - 3
A systematic review of pathophysiology and management of familial hyperaldosteronism type 1 in pregnancy.
Sanga V, Seccia TM, Rossi GP
Endocrine 2021; (74(1)):5-10 doi:10.1007/s12020-021-02763-5.
PMID: 34043182 - 4
A Chinese pedigree with glucocorticoid remediable aldosteronism.
Liu X, Jin L, Zhang H, et al.
Hypertension research : official journal of the Japanese Society of Hypertension 2021; (44(11)):1428-1433 doi:10.1038/s41440-021-00685-3.
PMID: 34462604 - 5
Differences in the clinical and hormonal presentation of patients with familial and sporadic primary aldosteronism.
Araujo-Castro M, Parra P, Martín Rojas-Marcos P, et al.
Frontiers in endocrinology 2024; (15()):1336306 doi:10.3389/fendo.2024.1336306.
PMID: 38495792 - 6
Intracranial aneurysm in a patient with glucocorticoid-remediable aldosteronism.
Al Romhain B, Young AM, Battacharya JJ, Suttner N
British journal of neurosurgery 2015; (29(5)):715-7 doi:10.3109/02688697.2015.1023775.
PMID: 26021674 - 7
A Case of Glucocorticoid Remediable Aldosteronism and Thoracoabdominal Aneurysms.
Shahrrava A, Moinuddin S, Boddu P, Shah R
Case reports in endocrinology 2016; (2016()):2017571 doi:10.1155/2016/2017571.
PMID: 27366333 - 8
Glucocorticoid Remediable Aldosteronism in a Family with a Strong History of Cerebral Aneurysms and Hypertension.
Zeman J, Kamilaris C
Prague medical report 2025; (126(3)):151-154 doi:10.14712/23362936.2025.23.
PMID: 40966436
This page is for informational purposes only and does not constitute medical advice. Ask your clinician to interpret your blood pressure, potassium, and imaging needs, and seek emergency care for sudden neurological, vision, chest, or back symptoms.